BioCryst Pharmaceuticals, Inc. (BCRX)
NASDAQ: BCRX · Real-Time Price · USD
7.39
+0.17 (2.35%)
Apr 17, 2025, 4:00 PM EDT - Market closed
BioCryst Pharmaceuticals Employees
BioCryst Pharmaceuticals had 580 employees as of December 31, 2024. The number of employees increased by 44 or 8.21% compared to the previous year.
Employees
580
Change (1Y)
44
Growth (1Y)
8.21%
Revenue / Employee
$777,090
Profits / Employee
-$153,243
Market Cap
1.55B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
BCRX News
- 14 days ago - BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 16 days ago - BioCryst to Present at Upcoming Investor Conference - GlobeNewsWire
- 7 weeks ago - BioCryst: Orladeyo's Expansion Is Just Getting Started - Seeking Alpha
- 7 weeks ago - BioCryst: Hold Steady As Orladeyo Builds, But Competition Heats Up - Seeking Alpha
- 7 weeks ago - BioCryst: Upgrading On Strong 2024 Orladeyo Sales, But I Remain Skeptical - Seeking Alpha
- 7 weeks ago - BioCryst Pharmaceuticals, Inc. (BCRX) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - BioCryst Pharmaceuticals Unveils Latest Trial Data, Reports Mixed Q4 Earnings - Benzinga
- 7 weeks ago - BioCryst Reports Fourth Quarter and Full Year 2024 Financial Results and Upcoming Key Milestones - GlobeNewsWire